These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 26214254)

  • 21. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis.
    Miyakawa H; Tanaka A; Selmi C; Hosoya N; Mataki N; Kikuchi K; Kato T; Arai J; Goto T; Gershwin ME
    Clin Dev Immunol; 2006; 13(2-4):289-94. PubMed ID: 17162370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: implications for molecular mimicry.
    Teoh KL; Mackay IR; Rowley MJ; Fussey SP
    Hepatology; 1994 Apr; 19(4):1029-33. PubMed ID: 8138243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope.
    Leung PS; Chuang DT; Wynn RM; Cha S; Danner DJ; Ansari A; Coppel RL; Gershwin ME
    Hepatology; 1995 Aug; 22(2):505-13. PubMed ID: 7543435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary biliary cirrhosis. Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1 alpha, a non-lipoic acid containing mitochondrial enzyme.
    Fregeau DR; Roche TE; Davis PA; Coppel R; Gershwin ME
    J Immunol; 1990 Mar; 144(5):1671-6. PubMed ID: 2106552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative epitope mapping of murine monoclonal and human autoantibodies to human PDH-E2, the major mitochondrial autoantigen of primary biliary cirrhosis.
    Surh CD; Ahmed-Ansari A; Gershwin ME
    J Immunol; 1990 Apr; 144(7):2647-52. PubMed ID: 1690773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of combinatorial human autoantibodies against PDC-E2 and biliary epithelial cells in patients with primary biliary cirrhosis.
    Cha S; Leung PS; Coppel RL; Van de Water J; Ansari AA; Gershwin ME
    Hepatology; 1994 Sep; 20(3):574-83. PubMed ID: 7521314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex.
    Fregeau DR; Davis PA; Danner DJ; Ansari A; Coppel RL; Dickson ER; Gershwin ME
    J Immunol; 1989 Jun; 142(11):3815-20. PubMed ID: 2715637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine specificity of T cells reactive to human PDC-E2 163-176 peptide, the immunodominant autoantigen in primary biliary cirrhosis: implications for molecular mimicry and cross-recognition among mitochondrial autoantigens.
    Shigematsu H; Shimoda S; Nakamura M; Matsushita S; Nishimura Y; Sakamoto N; Ichiki Y; Niho Y; Gershwin ME; Ishibashi H
    Hepatology; 2000 Nov; 32(5):901-9. PubMed ID: 11050037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies against mitochondrial dehydrogenase complexes in primary biliary cirrhosis.
    Yoshida T; Bonkovsky H; Ansari A; Danner D
    Gastroenterology; 1990 Jul; 99(1):187-94. PubMed ID: 2188870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis.
    Long SA; Quan C; Van de Water J; Nantz MH; Kurth MJ; Barsky D; Colvin ME; Lam KS; Coppel RL; Ansari A; Gershwin ME
    J Immunol; 2001 Sep; 167(5):2956-63. PubMed ID: 11509645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ursodeoxycholic acid treatment lowers the serum level of antibodies against pyruvate dehydrogenase and influences their inhibitory capacity for the enzyme complex in patients with primary biliary cirrhosis.
    Kisand KE; Karvonen AL; Vuoristo M; Färkkilä M; Lehtola J; Inkovaara J; Kisand KV; Miettinen T; Krohn K; Uibo R
    J Mol Med (Berl); 1996 May; 74(5):269-72. PubMed ID: 8773263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated enzymatic mitochondrial antibody assay for the diagnosis of primary biliary cirrhosis.
    Jensen WA; Jois JA; Murphy P; De Giorgio J; Brown B; Rowley MJ; Mackay IR
    Clin Chem Lab Med; 2000 Aug; 38(8):753-8. PubMed ID: 11071069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex.
    Moteki S; Leung PS; Dickson ER; Van Thiel DH; Galperin C; Buch T; Alarcon-Segovia D; Kershenobich D; Kawano K; Coppel RL
    Hepatology; 1996 Mar; 23(3):436-44. PubMed ID: 8617422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity.
    Bogdanos DP; Baum H; Gunsar F; Arioli D; Polymeros D; Ma Y; Burroughs AK; Vergani D
    Scand J Gastroenterol; 2004 Oct; 39(10):981-7. PubMed ID: 15513338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display.
    Ikuno N; Scealy M; Davies JM; Whittingham SF; Omagari K; Mackay IR; Rowley MJ
    Hepatology; 2001 Sep; 34(3):478-86. PubMed ID: 11526532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of PDC-E2 human combinatorial autoantibodies by peptide mimotopes.
    Leung PS; Cha S; Joplin RE; Galperin C; Van de Water J; Ansari AA; Coppel RL; Schatz PJ; Cwirla S; Fabris LE; Neuberger JM; Gershwin ME
    J Autoimmun; 1996 Dec; 9(6):785-93. PubMed ID: 9115581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epitope mapping on E1alpha subunit of pyruvate dehydrogenase complex with autoantibodies of patients with primary biliary cirrhosis.
    Mori T; Ono K; Hakozaki M; Kochi H
    Liver Int; 2003 Oct; 23(5):355-62. PubMed ID: 14708897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme-linked immunosorbent assays for the determination of IgG, IgA, and IgM autoantibodies to pyruvate dehydrogenase in primary biliary cirrhosis.
    Kisand K; Kisand K; Salupere V; Uibo R
    Int J Clin Lab Res; 1994; 24(2):98-101. PubMed ID: 7919436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme inhibitory antibody to pyruvate dehydrogenase: diagnostic utility in primary biliary cirrhosis.
    Jois J; Omagari K; Rowley MJ; Anderson J; Mackay IR
    Ann Clin Biochem; 2000 Jan; 37 ( Pt 1)():67-73. PubMed ID: 10672375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis.
    Van de Water J; Ansari AA; Surh CD; Coppel R; Roche T; Bonkovsky H; Kaplan M; Gershwin ME
    J Immunol; 1991 Jan; 146(1):89-94. PubMed ID: 1984455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.